{"id":40313,"date":"2022-08-12T13:46:14","date_gmt":"2022-08-12T13:46:14","guid":{"rendered":"http:\/\/nationaltimes.pk\/eng\/?p=40313"},"modified":"2022-08-12T13:46:14","modified_gmt":"2022-08-12T13:46:14","slug":"roche-gets-u-s-approval-for-flu-drug-for-children-aged-5-and-over","status":"publish","type":"post","link":"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/","title":{"rendered":"Roche gets U.S. approval for flu drug for children aged 5 and over"},"content":{"rendered":"<p>ZURICH (National Times) &#8211; Roche (ROG.S) has received approval from the U.S. Food and Drugs Administration for its Xofluza drug to treat influenza in children aged five years and older, the drugmaker said on Friday.<\/p>\n<p>The medicine has been approved to treat acute uncomplicated influenza in otherwise healthy children who have shown symptoms for no more than 48 hours.<br \/>\nThe FDA also approved Xofluza to prevent influenza in children aged five years and above following contact with an infected person.<\/p>\n<p>The drug becomes the first single-dose oral influenza medicine approved in the United States for children in this age group, Roche said. Xofluza is already FDA-approved to treat influenza in people aged 12 and above.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ZURICH (National Times) &#8211; Roche (ROG.S) has received approval from the U.S. Food and Drugs Administration for its Xofluza drug to treat influenza in children aged five years and older, the drugmaker said on Friday. The medicine has been approved to treat acute uncomplicated influenza in otherwise healthy children who have shown symptoms for no [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":40316,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-40313","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","entry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Roche gets U.S. approval for flu drug for children aged 5 and over - Nation<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Roche gets U.S. approval for flu drug for children aged 5 and over - Nation\" \/>\n<meta property=\"og:description\" content=\"ZURICH (National Times) &#8211; Roche (ROG.S) has received approval from the U.S. Food and Drugs Administration for its Xofluza drug to treat influenza in children aged five years and older, the drugmaker said on Friday. The medicine has been approved to treat acute uncomplicated influenza in otherwise healthy children who have shown symptoms for no [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/\" \/>\n<meta property=\"og:site_name\" content=\"Nation\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-12T13:46:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nationaltimes.pk\/eng\/wp-content\/uploads\/2022\/08\/Untitled-1-270.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"670\" \/>\n\t<meta property=\"og:image:height\" content=\"360\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"adminnation\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminnation\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/\",\"url\":\"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/\",\"name\":\"Roche gets U.S. approval for flu drug for children aged 5 and over - Nation\",\"isPartOf\":{\"@id\":\"https:\/\/nationaltimes.pk\/eng\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/nationaltimes.pk\/eng\/wp-content\/uploads\/2022\/08\/Untitled-1-270.jpg\",\"datePublished\":\"2022-08-12T13:46:14+00:00\",\"author\":{\"@id\":\"https:\/\/nationaltimes.pk\/eng\/#\/schema\/person\/96dc24980f85ecafe26ade8fe4748f0f\"},\"breadcrumb\":{\"@id\":\"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/#primaryimage\",\"url\":\"https:\/\/nationaltimes.pk\/eng\/wp-content\/uploads\/2022\/08\/Untitled-1-270.jpg\",\"contentUrl\":\"https:\/\/nationaltimes.pk\/eng\/wp-content\/uploads\/2022\/08\/Untitled-1-270.jpg\",\"width\":670,\"height\":360},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/nationaltimes.pk\/eng\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Roche gets U.S. approval for flu drug for children aged 5 and over\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/nationaltimes.pk\/eng\/#website\",\"url\":\"https:\/\/nationaltimes.pk\/eng\/\",\"name\":\"Nation\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/nationaltimes.pk\/eng\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/nationaltimes.pk\/eng\/#\/schema\/person\/96dc24980f85ecafe26ade8fe4748f0f\",\"name\":\"adminnation\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/nationaltimes.pk\/eng\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7f4e66ad9f5639ba3a6f846e43d55d93ee5fd5f30b5c5a10f4cd223008e8fa10?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7f4e66ad9f5639ba3a6f846e43d55d93ee5fd5f30b5c5a10f4cd223008e8fa10?s=96&d=mm&r=g\",\"caption\":\"adminnation\"},\"sameAs\":[\"https:\/\/nationaltimes.pk\/eng\/\"],\"url\":\"https:\/\/nationaltimes.pk\/eng\/author\/adminnation\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Roche gets U.S. approval for flu drug for children aged 5 and over - Nation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/","og_locale":"en_US","og_type":"article","og_title":"Roche gets U.S. approval for flu drug for children aged 5 and over - Nation","og_description":"ZURICH (National Times) &#8211; Roche (ROG.S) has received approval from the U.S. Food and Drugs Administration for its Xofluza drug to treat influenza in children aged five years and older, the drugmaker said on Friday. The medicine has been approved to treat acute uncomplicated influenza in otherwise healthy children who have shown symptoms for no [&hellip;]","og_url":"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/","og_site_name":"Nation","article_published_time":"2022-08-12T13:46:14+00:00","og_image":[{"width":670,"height":360,"url":"https:\/\/nationaltimes.pk\/eng\/wp-content\/uploads\/2022\/08\/Untitled-1-270.jpg","type":"image\/jpeg"}],"author":"adminnation","twitter_card":"summary_large_image","twitter_misc":{"Written by":"adminnation","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/","url":"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/","name":"Roche gets U.S. approval for flu drug for children aged 5 and over - Nation","isPartOf":{"@id":"https:\/\/nationaltimes.pk\/eng\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/#primaryimage"},"image":{"@id":"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/#primaryimage"},"thumbnailUrl":"https:\/\/nationaltimes.pk\/eng\/wp-content\/uploads\/2022\/08\/Untitled-1-270.jpg","datePublished":"2022-08-12T13:46:14+00:00","author":{"@id":"https:\/\/nationaltimes.pk\/eng\/#\/schema\/person\/96dc24980f85ecafe26ade8fe4748f0f"},"breadcrumb":{"@id":"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nationaltimes.pk\/eng\/2022\/40313\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/#primaryimage","url":"https:\/\/nationaltimes.pk\/eng\/wp-content\/uploads\/2022\/08\/Untitled-1-270.jpg","contentUrl":"https:\/\/nationaltimes.pk\/eng\/wp-content\/uploads\/2022\/08\/Untitled-1-270.jpg","width":670,"height":360},{"@type":"BreadcrumbList","@id":"https:\/\/nationaltimes.pk\/eng\/2022\/40313\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nationaltimes.pk\/eng\/"},{"@type":"ListItem","position":2,"name":"Roche gets U.S. approval for flu drug for children aged 5 and over"}]},{"@type":"WebSite","@id":"https:\/\/nationaltimes.pk\/eng\/#website","url":"https:\/\/nationaltimes.pk\/eng\/","name":"Nation","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nationaltimes.pk\/eng\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/nationaltimes.pk\/eng\/#\/schema\/person\/96dc24980f85ecafe26ade8fe4748f0f","name":"adminnation","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nationaltimes.pk\/eng\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7f4e66ad9f5639ba3a6f846e43d55d93ee5fd5f30b5c5a10f4cd223008e8fa10?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7f4e66ad9f5639ba3a6f846e43d55d93ee5fd5f30b5c5a10f4cd223008e8fa10?s=96&d=mm&r=g","caption":"adminnation"},"sameAs":["https:\/\/nationaltimes.pk\/eng\/"],"url":"https:\/\/nationaltimes.pk\/eng\/author\/adminnation\/"}]}},"_links":{"self":[{"href":"https:\/\/nationaltimes.pk\/eng\/wp-json\/wp\/v2\/posts\/40313","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nationaltimes.pk\/eng\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nationaltimes.pk\/eng\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nationaltimes.pk\/eng\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nationaltimes.pk\/eng\/wp-json\/wp\/v2\/comments?post=40313"}],"version-history":[{"count":1,"href":"https:\/\/nationaltimes.pk\/eng\/wp-json\/wp\/v2\/posts\/40313\/revisions"}],"predecessor-version":[{"id":40318,"href":"https:\/\/nationaltimes.pk\/eng\/wp-json\/wp\/v2\/posts\/40313\/revisions\/40318"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nationaltimes.pk\/eng\/wp-json\/wp\/v2\/media\/40316"}],"wp:attachment":[{"href":"https:\/\/nationaltimes.pk\/eng\/wp-json\/wp\/v2\/media?parent=40313"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nationaltimes.pk\/eng\/wp-json\/wp\/v2\/categories?post=40313"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nationaltimes.pk\/eng\/wp-json\/wp\/v2\/tags?post=40313"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}